My Thoughts and Expressions
Kiran Mazumdar Shaw- Founder & Chairperson, Biocon Group If the 20th century was defined by energy security and the early 21st by digital sovereignty, the coming decades will be shaped by biotech sovereignty embedded in artificial intelligence. Nations that command the convergence of biology and AI will define the future of healthcare, food security, bio-manufacturing, … Continue reading India Must Build Biotech Sovereignty Embedded in AI
By Kiran Mazumdar-Shaw and Dr. Murali Panchapagesa Muthuswamy The global economy is on the cusp of a “biological industrial revolution”. Synthetic biology (SynBio)—the design and construction of new biological parts, devices, and systems—is no longer a niche academic pursuit but a disruptive force poised to rewire how we heal, feed, and fuel the world. For … Continue reading Engineering the Future: India’s Trillion-Dollar Synthetic Biology Opportunity
By Kiran Mazumdar-Shaw , Chairperson, Biocon Group India is at a defining moment in its scientific and economic journey. With the establishment of the Anusandhan National Research Foundation (ANRF), the country has made a bold commitment to nurture discovery-led research. But for this vision to translate into world-changing innovation, India must urgently address a critical … Continue reading India Must Enable Research-Stage Listings to Unlock the Next Wave of Innovation
By Kiran Mazumdar-Shaw, Chairperson, Biocon Group Last week, the PM stated in his Independence Day speech: ‘We are known as the ‘pharmacy of the world’. But isn’t it the need of the hour to invest more in R&D? Shouldn’t we be the ones providing the best and most affordable medicines for the welfare of humanity?’ … Continue reading From pharmacy to innovation hub: Why India needs a regulatory revolution in biotech
As the U.S. tightens its stance on bilateral trade, imposing higher tariffs on Indian pharmaceutical products could be counterproductive, warns Kiran Mazumdar-Shaw, Chairperson, Biocon Group. Speaking at the Asia Economic Dialogue 2025, she emphasized the risks of disrupting global healthcare supply chains. “A global reset is clearly visible in the form of decoupling and rising … Continue reading Reappraising India’s Role in Global Healthcare
By Kiran Mazumdar-Shaw, Chairperson, Biocon Group India’s pivotal role in global health security has never been more vital, especially in light of the rising healthcare costs that are putting immense pressure on households, governments, insurers, and healthcare providers worldwide. In 2022, global healthcare spending reached an alarming USD 9.8 trillion, accounting for around 10% of … Continue reading India Provides Health Security, Not Just Affordable Drugs, to the World
By Kiran Mazumdar-Shaw, Chairperson, Biocon Group The Union Budget for FY25-26 is reassuring, as it instils confidence that India is investing in the right areas to drive stable and inclusive economic growth. The eighth consecutive Budget presented by Finance Minister Nirmala Sitharaman is directionally very positive as it addresses key sectors such as healthcare, research … Continue reading A Stable Budget That Could Have Been More Strategic to Enhance Global Competitiveness
By Kiran Mazumdar-Shaw, Chairperson, Biocon Group Pre-budget opinion published in a leading business publication. (Union Budget of India 2025) Finance Minister Nirmala Sitharaman is all set to present the Budget for FY25-26 on February 1, 2025. The upcoming Union Budget presents a unique opportunity to accelerate the growth of India’s pharmaceutical and life sciences sector. … Continue reading Strategic Budget Interventions Can Position Indian Pharma for Global Leadership
Biotechnology is emerging as one of the most transformative fields of our time, offering solutions to critical challenges in health, agriculture and sustainability. For India, the journey toward technology sovereignty in this sector represents not only a vision for self-reliance but also an opportunity to establish itself as a global biotech powerhouse. Economic and Strategic … Continue reading Kiran Mazumdar-Shaw Writes: Biotechnology is Key to Tech Transformation
- By Kiran Mazumdar-Shaw India's biopharmaceutical sector achieved significant milestones in 2024, reinforcing its position as a global leader in affordable healthcare solutions. The industry's focus on biologics, vaccines, medical devices, and diagnostics has made a difference to the lives of nearly every Indian and millions more globally. The biopharma sector has emerged as a … Continue reading Year-End Reflections: Driving India’s Bio-Revolution